I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Study of Poziotinib in Japanese Patients With NSCLC
A Phase 1/2, open-label, multicenter study to determine dose, tolerability, safety and efficacy of poziotinib in Japanese patients non-small cell lung cancer (NSCLC).
systemic therapy
EGFR
HER2
neuropathy
poziotinib
- 0 views
- 19 Feb, 2024